Drowsiness, anxiety, irritability, urinary retention, dry mouth, constipation, mydriasis, tachycardia. Treatment: removal of the drug, gastric lavage, activated charcoal, symptomatic therapy. The pharmacokinetic interactions with pseudoephedrine, cimetidine, ketoconazole, erythromycin, azithromycin, diazepam and glipizide were found.
Concomitant use with dianabol theophylline (400 mg / day) reduces total clearance of cetirizine (kinetics of theophylline is not changed).
Myelotoxic drugs increase the expression gematotoksichnosti cetirizine.
The use of cetirizine should be stopped for three days prior to the allergy testing.
We recommend caution with concomitant use of drugs that have a depressant effect on the central nervous system.
Some patients have long-term treatment with cetirizine -Teva may increase the risk of caries due to dryness in the oral cavity. For this reason, at the time of treatment needs careful oral hygiene.
With careful use of Cetirizine -Teva drug in patients with chronic renal failure secondary to severe, in elderly patients (possibly decreased glomerular filtration).
The drug -Teva Cetirizine may potentiate the effects of alcohol, so it is recommended to refrain from drinking alcohol while using the drug. Patients with hereditary galactose intolerance, lactase deficiency and malabsorption of glucose-galactose preparation dianabol is contraindicated.
Effects on ability to drive a car, and management mechanisms
should be careful while using the drug cetirizine -dianabol due to possible adverse reactions that may adversely affect the ability to drive vehicles and the performance of potentially hazardous activities that require high concentration and speed of psychomotor reactions.